South Korea
· Delayed Price · Currency is KRW JW Pharmaceutical Statistics
Total Valuation
KRX:001060 has a market cap or net worth of KRW 512.45 billion. The enterprise value is 537.72 billion.
| Market Cap | 512.45B |
| Enterprise Value | 537.72B |
Important Dates
The next estimated earnings date is Thursday, August 14, 2025.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
KRX:001060 has 22.88 million shares outstanding. The number of shares has decreased by -2.18% in one year.
| Current Share Class | 22.54M |
| Shares Outstanding | 22.88M |
| Shares Change (YoY) | -2.18% |
| Shares Change (QoQ) | -0.50% |
| Owned by Insiders (%) | 0.82% |
| Owned by Institutions (%) | 10.98% |
| Float | 12.89M |
Valuation Ratios
The trailing PE ratio is 8.95 and the forward PE ratio is 6.50.
| PE Ratio | 8.95 |
| Forward PE | 6.50 |
| PS Ratio | 0.71 |
| PB Ratio | 1.55 |
| P/TBV Ratio | 1.60 |
| P/FCF Ratio | 8.28 |
| P/OCF Ratio | 7.08 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.45, with an EV/FCF ratio of 8.69.
| EV / Earnings | 9.26 |
| EV / Sales | 0.74 |
| EV / EBITDA | 5.45 |
| EV / EBIT | 6.73 |
| EV / FCF | 8.69 |
Financial Position
The company has a current ratio of 1.48, with a Debt / Equity ratio of 0.24.
| Current Ratio | 1.48 |
| Quick Ratio | 0.84 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | 0.82 |
| Debt / FCF | 1.29 |
| Interest Coverage | 9.35 |
Financial Efficiency
Return on equity (ROE) is 20.59% and return on invested capital (ROIC) is 11.72%.
| Return on Equity (ROE) | 20.59% |
| Return on Assets (ROA) | 7.73% |
| Return on Invested Capital (ROIC) | 11.72% |
| Return on Capital Employed (ROCE) | 20.03% |
| Revenue Per Employee | 677.92M |
| Profits Per Employee | 54.35M |
| Employee Count | 1,068 |
| Asset Turnover | 1.14 |
| Inventory Turnover | 3.42 |
Taxes
In the past 12 months, KRX:001060 has paid 16.42 billion in taxes.
| Income Tax | 16.42B |
| Effective Tax Rate | 20.82% |
Stock Price Statistics
The stock price has decreased by -21.58% in the last 52 weeks. The beta is 1.05, so KRX:001060's price volatility has been similar to the market average.
| Beta (5Y) | 1.05 |
| 52-Week Price Change | -21.58% |
| 50-Day Moving Average | 22,362.00 |
| 200-Day Moving Average | 24,071.70 |
| Relative Strength Index (RSI) | 45.80 |
| Average Volume (20 Days) | 71,586 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:001060 had revenue of KRW 724.02 billion and earned 58.05 billion in profits. Earnings per share was 2,492.80.
| Revenue | 724.02B |
| Gross Profit | 324.65B |
| Operating Income | 78.48B |
| Pretax Income | 78.84B |
| Net Income | 58.05B |
| EBITDA | 97.36B |
| EBIT | 78.48B |
| Earnings Per Share (EPS) | 2,492.80 |
Balance Sheet
The company has 54.42 billion in cash and 79.69 billion in debt, giving a net cash position of -25.27 billion or -1,104.47 per share.
| Cash & Cash Equivalents | 54.42B |
| Total Debt | 79.69B |
| Net Cash | -25.27B |
| Net Cash Per Share | -1,104.47 |
| Equity (Book Value) | 331.09B |
| Book Value Per Share | 14,331.81 |
| Working Capital | 104.34B |
Cash Flow
In the last 12 months, operating cash flow was 72.40 billion and capital expenditures -10.52 billion, giving a free cash flow of 61.87 billion.
| Operating Cash Flow | 72.40B |
| Capital Expenditures | -10.52B |
| Free Cash Flow | 61.87B |
| FCF Per Share | 2,704.23 |
Margins
Gross margin is 44.84%, with operating and profit margins of 10.84% and 8.62%.
| Gross Margin | 44.84% |
| Operating Margin | 10.84% |
| Pretax Margin | 10.89% |
| Profit Margin | 8.62% |
| EBITDA Margin | 13.45% |
| EBIT Margin | 10.84% |
| FCF Margin | 8.55% |
Dividends & Yields
This stock pays an annual dividend of 450.00, which amounts to a dividend yield of 2.02%.
| Dividend Per Share | 450.00 |
| Dividend Yield | 2.02% |
| Dividend Growth (YoY) | 12.50% |
| Years of Dividend Growth | 9 |
| Payout Ratio | 15.48% |
| Buyback Yield | 2.18% |
| Shareholder Yield | 4.17% |
| Earnings Yield | 11.33% |
| FCF Yield | 12.07% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 27, 2023. It was a forward split with a ratio of 1.02.
| Last Split Date | Dec 27, 2023 |
| Split Type | Forward |
| Split Ratio | 1.02 |
Scores
KRX:001060 has an Altman Z-Score of 3.56 and a Piotroski F-Score of 7.
| Altman Z-Score | 3.56 |
| Piotroski F-Score | 7 |